FILE PHOTO: The Alzheimer’s drug LEQEMBI is seen in this undated handout image obtained by Reuters on January 20, 2023. Eisai/Handout via REUTERS/File Photo
Join the Investing Wealth Daily Community now with our Free newsletter.
Discover new market trends and ideas directly to your inbox.
Recent Posts
- US existing home sales drop in August; supply improves
- US-listed crypto stocks jump after bumper rate cut from Fed
- Delta to pause flights between New York and Tel Aviv
- BMO raises S&P 500 target for 2024 to 6,100 from 5,600
- Facebook parent Meta Platforms beats lawsuit over Apple privacy, Sandberg disclosures